Faron Pharmaceuticals Oy (FARN) Competitors GBX 221.50 -8.50 (-3.70%) As of 08/22/2025 11:50 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesInsider TradesBuy This Stock FARN vs. ERGO, OXB, SLN, PRTC, HZD, VRP, AVCT, ARIX, CIR, and BVXPShould you be buying Faron Pharmaceuticals Oy stock or one of its competitors? The main competitors of Faron Pharmaceuticals Oy include Ergomed (ERGO), Oxford Biomedica (OXB), Silence Therapeutics (SLN), PureTech Health (PRTC), Horizon Discovery Group plc (HZD.L) (HZD), Verona Pharma plc (VRP.L) (VRP), Avacta Group (AVCT), Arix Bioscience (ARIX), Circassia Group (CIR), and Bioventix (BVXP). These companies are all part of the "biotechnology" industry. Faron Pharmaceuticals Oy vs. Its Competitors Ergomed Oxford Biomedica Silence Therapeutics PureTech Health Horizon Discovery Group plc (HZD.L) Verona Pharma plc (VRP.L) Avacta Group Arix Bioscience Circassia Group Bioventix Ergomed (LON:ERGO) and Faron Pharmaceuticals Oy (LON:FARN) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, institutional ownership, earnings, dividends, media sentiment, valuation, profitability and analyst recommendations. Which has more risk & volatility, ERGO or FARN? Ergomed has a beta of 0.79, suggesting that its share price is 21% less volatile than the S&P 500. Comparatively, Faron Pharmaceuticals Oy has a beta of 0.36, suggesting that its share price is 64% less volatile than the S&P 500. Does the media prefer ERGO or FARN? In the previous week, Faron Pharmaceuticals Oy had 3 more articles in the media than Ergomed. MarketBeat recorded 3 mentions for Faron Pharmaceuticals Oy and 0 mentions for Ergomed. Faron Pharmaceuticals Oy's average media sentiment score of 0.47 beat Ergomed's score of 0.00 indicating that Faron Pharmaceuticals Oy is being referred to more favorably in the news media. Company Overall Sentiment Ergomed Neutral Faron Pharmaceuticals Oy Neutral Which has better earnings and valuation, ERGO or FARN? Ergomed has higher revenue and earnings than Faron Pharmaceuticals Oy. Faron Pharmaceuticals Oy is trading at a lower price-to-earnings ratio than Ergomed, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioErgomed£152.09M0.00£15M£0.29N/AFaron Pharmaceuticals OyN/AN/A-£60.23M-£37.39-5.92 Is ERGO or FARN more profitable? Ergomed has a net margin of 9.87% compared to Faron Pharmaceuticals Oy's net margin of 0.00%. Ergomed's return on equity of 18.08% beat Faron Pharmaceuticals Oy's return on equity.Company Net Margins Return on Equity Return on Assets Ergomed9.87% 18.08% 10.16% Faron Pharmaceuticals Oy N/A 0.46%-70.00% Do insiders and institutionals hold more shares of ERGO or FARN? 71.1% of Ergomed shares are owned by institutional investors. Comparatively, 10.7% of Faron Pharmaceuticals Oy shares are owned by institutional investors. 18.2% of Ergomed shares are owned by company insiders. Comparatively, 31.8% of Faron Pharmaceuticals Oy shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. SummaryErgomed beats Faron Pharmaceuticals Oy on 9 of the 12 factors compared between the two stocks. Get Faron Pharmaceuticals Oy News Delivered to You Automatically Sign up to receive the latest news and ratings for FARN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding FARN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FARN vs. The Competition Export to ExcelMetricFaron Pharmaceuticals OyBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£297.37M£137.09M£5.76B£3.22BDividend YieldN/A3.74%4.41%5.04%P/E Ratio-5.923.8731.22164.70Price / SalesN/A4,057.33435.13310,111.41Price / Cash20.0013.1937.7327.93Price / Book0.1146.309.535.91Net Income-£60.23M-£90.99M£3.26B£5.89B7 Day Performance4.53%0.42%2.11%49.54%1 Month Performance12.15%3.47%2.80%56.40%1 Year Performance28.03%205.44%30.59%136.21% Faron Pharmaceuticals Oy Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FARNFaron Pharmaceuticals OyN/AGBX 221.50-3.7%N/A+29.9%£297.37MN/A-5.9234Gap UpERGOErgomedN/AN/AN/AN/A£701.00M£152.09M4,641.386OXBOxford Biomedica1.5659 of 5 starsGBX 534+6.4%GBX 410.33-23.2%+54.7%£567.65M£98.31M-3.97891News CoverageInsider TradeSLNSilence TherapeuticsN/AN/AN/AN/A£480.35M£11.35M-11.01100High Trading VolumePRTCPureTech Health2.0053 of 5 starsGBX 133.80+0.3%GBX 455+240.1%-16.2%£401.91M£521.32K-5.49300News CoverageHZDHorizon Discovery Group plc (HZD.L)N/AN/AN/AN/A£302.98M£54.63M-33.55416VRPVerona Pharma plc (VRP.L)N/AN/AN/AN/A£228MN/A-1.6822Gap UpAVCTAvacta GroupN/AGBX 49+1.0%N/A-35.9%£186.15M£26.29M-6.31120News CoverageARIXArix BioscienceN/AN/AN/AN/A£183.73M£14.16M1,290.919CIRCircassia GroupN/AN/AN/AN/A£142.66M£27.90M3,400.00111Gap DownBVXPBioventixN/AGBX 2,471-0.2%N/A-43.7%£129.39M£13.65M15.9812Negative NewsHigh Trading Volume Related Companies and Tools Related Companies Ergomed Alternatives Oxford Biomedica Alternatives Silence Therapeutics Alternatives PureTech Health Alternatives Horizon Discovery Group plc (HZD.L) Alternatives Verona Pharma plc (VRP.L) Alternatives Avacta Group Alternatives Arix Bioscience Alternatives Circassia Group Alternatives Bioventix Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:FARN) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Faron Pharmaceuticals Oy Please log in to your account or sign up in order to add this asset to your watchlist. Share Faron Pharmaceuticals Oy With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access